Molecular docking studies of Rhizophora mucronata alkaloids against neuroinflammatory marker cyclooxygenase 2

International Journal of Biological Chemistry

Volumn 8, Issue 2, 2014, Pages 91-99

  Manigandan, V ^a   Gurudeeban, S ^a   Satyavani, K ^a   Ramanathan, T ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Ajmalicine; Amino acid; Auto dock; Binding energy; COX2; Neuro inflammation

Indexed keywords

EID: 84907209097     PISSN: 1819155X     EISSN: 21522561     Source Type: Journal    
DOI: 10.3923/ijbc.2014.91.99     Document Type: Article

References (21)

1. Breder, CD., 1997. Cyclooxygenase systems in the mammalian brain. Ann. N. Y. Acad. Sci., 813:296-301.
2. Carter, J. S, 2000. Inhibition of cyclooxygenase-2. Exp. Opm. Ther. Patents, 10: 1011-1020.
3. Chen, J.W, H. Ma, X.N. Huang, Q.H. Gong, Q. Wu and J.S. Shi, 2008. Improvement of Dendrobium nobile Lindl. alkaloids on cognitive deficit in rats induced by lipopolysaccharides. Chin. J. Pharmacol. Toxicol, 22: 406-411.
4. Espeland, M.A, S.R. Rapp, S.A. Shumaker, R. Brunner and J.E. Manson et al. 2004. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's health initiative memory study. J. Am. Med. Assoc, 291: 2959-2968.
5. Gurudeeban, S, K. Satyavani, T. Ramanathan and P. Ravikumar, 2012. Dipeptidyl peptidase IV inhibitors derived from a mangrove flora Rhizophora mucronata: An in silico approach. Bangladesh J. Pharmacol, 7: 203-210.
6. Gurudeeban, S, T. Ramanathan and K. Satyavani, 2013. Antimicrobial and radical scavenging effects of alkaloid extracts from Rhizophora mucronata. Pharm. Chem. J, 47: 50-53.
7. Jimeno, J, G. Faircloth, J.M. Sousa-Faro, P. Scheuer and K. Rinehart, 2004. New marine derived anticancer therapeutics: A journey from the sea to clinical trials. Marine Drugs, 2: 14-29.
8. Kulkarni, A.P, L.A. Kellaway and G.J. Kotwal, 2005. Herbal complement inhibitors in the treatment of neuroinflammation: Future strategy for neuroprotection. Ann. N. Y. Acad. Sci, 1056: 413-429.
9. Lee, E.O, Y.J. Shin and Y.H. Chong, 2004. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-a: Possible involvement of multiple signal transduction and β-catenin/T-cell factor. J. Neuroimmunol, 155: 21-31.
10. Maccioni, R.B, L.E. Rojo, J. A. Fernandez and R.O. Kuljis, 2009. The role of neuroimmunomodulation in Alzheimer's disease. Ann. N. Y. Acad. Sci, 1153: 240-246.
11. O'Banion, M.K, J.C. Miller, J.W. Chang, M.D. Kaplan and P.D. Coleman, 1996. Interleukin-ip induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem, 66: 2532-2540.
12. Phillis, J.W, L.A. Horrocks and A.A. Farooqui, 2006. Cyclooxygenases, lipoxygenases and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Res. Rev, 52: 201-243.
13. Ramanathan, T, 2000. Studies on medicinal plants of Parangipettai Coast (Southeast coast of India). Ph.D. Thesis, Annamalai University, India.
14. Rogers, J, D. Mastroeni, B. Leonard, J. Joyce and A. Grover, 2007. Neuroinflammation in Alzheimer's disease and Parkinson's disease: Are microglia pathogenic in either disorder? Int. Rev. Neurobiol, 82: 235-246.
15. Scatena, R, G.E. Martorana, P. Bottoni, G. Botta, P. Pastore and B. Giardina, 2007. An update on pharmacological approaches to neurodegenerative diseases. Exp. Opin. Invest. Drugs, 16: 59-72.
16. Stefanovic, B, F. Bosetti and A.C. Silva, 2006. Modulatory role of cyclooxygenase-2 in cerebrovascular coupling. Neuroimage, 32: 23-32.
17. Townsend, K.P. and D. Pratico, 2005. Novel therapeutic opportunities for Alzheimer's disease: Focus on nonsteroidal anti-inflammatory drugs. FASEB J, 19: 1592-1601.
18. Van Ryn, J, G. Trummlitz and M. Pairet, 2000. COX-2 selectivity and inflammatory processes. Curr. Med. Chem, 7: 1145-1161.
19. Verrico, M.M., R.J. Weber, T.P. McKaveney, N.T. Ansani and A.L. Towers, 2003. Adverse drug events involving COX-2 inhibitors. Ann. Pharmacother., 37: 1203-1213.
20. Zhang, S., K. Kumar, X. Jiang, A. Wallqvist and J. Reifman, 2008. DOVIS: An implementation for high-throughput virtual screening using AutoDock. BMC Bioinformt., Vol. 9. 10.1186/1471-2105-9-126
21. Zilka, N., M. Ferencik and I. Hulin, 2006. Neuroinfianimation in Alzheimer's disease: Protector or promoter? Bratislavske Lekarske Listy, 107: 374-383.